340B Advocacy Alliance Bulletin

On Feb. 2, a bipartisan group of six senators released a draft bill called the Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future (SUSTAIN) 340B Act.
The AHA 340B Alliance Feb. 22 at 3 p.m. ET will host a call for AHA members about a discussion draft of legislation to provide “clarity, transparency and accountability to the 340B program.”
AHA Dec. 22 filed a friend-of-the-court brief in support of a Louisiana law that prohibits drug companies from denying Louisiana hospitals the same 340B discounts for drugs dispensed at community pharmacies that would be provided via in-house pharmacies.
Following last year’s unanimous Supreme Court decision in favor of the AHA and others, the Department of Health and Human Services Nov. 2 issued a final rule outlining the agency’s remedy for the unlawful payment cuts to certain hospitals that participate in the 340B Drug Pricing Program.
To assist members in their efforts to obtain reimbursement under their contracts with their MAO plans, we have identified and spoken with four outside law firms that have considerable experience with 340B questions and litigating against insurers on issues like these.
Report: 340B tax-exempt hospitals provided more than $84 billion benefits to communities in 2020
Digital ad campaign highlights how the 340B program supports patients and communities .